Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Pak J Pharm Sci ; 37(2(Special)): 459-462, 2024 Mar.
Article de Anglais | MEDLINE | ID: mdl-38822550

RÉSUMÉ

The purpose of this study was to examine the potential hypoglycemic effects of administering ginger (Zingiber officinale) and garlic (Allium sativum) to rats with induced type 2 diabetes. A total of forty-five male adult albino rats were randomly assigned to five groups. The groups were named Normal Control, Diabetic Control, Ginger group, Garlic group and a combination group of ginger and garlic. Diabetes was produced in all groups, except the normal control group, using an intraperitoneal injection of streptozotocin at a dosage of 60 mg/body weight. During the course of two months, rats were administered varying amounts of ginger and garlic powders as part of their treatment After the experiment concluded, measurements were taken for glycated hemoglobin, serum glucose, insulin, cholesterol, high density protein, low density protein and liver glycogen levels. These groups exhibited considerably greater serum insulin and high-density lipoprotein concentrations (P<0.05) compared to the diabetic control group. Conversely, body weight, fasting blood glucose, total cholesterol, low density lipoprotein, and glycated hemoglobin levels were significantly lower (P<0.05) in all groups compared to the diabetic control group. A statistically significant increase (P<0.05) increase shown in liver glycogen levels. This study proposes that the utilization of ginger and garlic powders improve the condition of type 2 diabetes and maybe reduce the risk of subsequent diabetic complications.


Sujet(s)
Glycémie , Diabète expérimental , Ail , Hypoglycémiants , Insuline , Poudres , Zingiber officinale , Animaux , Ail/composition chimique , Zingiber officinale/composition chimique , Diabète expérimental/traitement médicamenteux , Diabète expérimental/sang , Mâle , Glycémie/effets des médicaments et des substances chimiques , Glycémie/métabolisme , Hypoglycémiants/pharmacologie , Hypoglycémiants/usage thérapeutique , Rats , Insuline/sang , Diabète de type 2/traitement médicamenteux , Diabète de type 2/sang , Hémoglobine glyquée/métabolisme , Extraits de plantes/pharmacologie , Phytothérapie , Glycogène hépatique/métabolisme , Streptozocine
2.
Pak J Pharm Sci ; 33(6(Supplementary)): 2715-2719, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-33879429

RÉSUMÉ

The objective of this study to evaluate the effect of Resistant Starch (RS) on lipid profile, blood glucose, hormones and TNF-α in Type 2 Diabetes (T2DM). 45 Wister male rats were divided into 5 groups each having 9 rats: without T2DM negative control (NC) with T2DM positive control (PC), resistant starch: 0.20g/kg body weight (HM0.20), resistant starch: 0.30g/kg body weight (HM0.30) and resistant starch: 0.40g/kg body weight (HM0.40). Different levels were added in basal diets while negative and positive control received basal diet. Animals fed on different diets were induced type 2 diabetes 60mg/kg streptozotocin solution injected intraperitoneally in rats. Results of blood glucose showed significantly (P<0.05) lower in all rats fed HM0.20, HM0.30 and HM0.40. In case of lipid profile results indicated that HM0.04 showed significant (P<0.05) increase in HDL level while cholesterol, LDL, triglycerides were reduced. After treatment hormonal profile, leptin, insulin and TNF-α level were significantly (P<0.05) reduced. It may be concluded that RS is the new approach to treat the T2DM.


Sujet(s)
Diabète expérimental/diétothérapie , Amidon résistant/administration et posologie , Animaux , Glycémie/analyse , Diabète expérimental/métabolisme , Lipides/sang , Mâle , Rats , Rat Wistar , Streptozocine , Facteur de nécrose tumorale alpha/sang
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...